Pai Raveendra, Pai Aruna, Srivastava Birendra, Kohli Kanchan
Formulation Development Services, Matrix Laboratories Ltd., A Subsidiary of Mylan Inc., USA, Plot No. 34A, Bollaram Industrial Area, Jinnaram Mandal, Medak District, Hydrabad, India.
Comb Chem High Throughput Screen. 2011 Feb;14(2):138-45. doi: 10.2174/138620711794474042.
Powder layering technique was evaluated using laboratory scale centrifugal granulator instrument to prepare extended release pellet dosage form of ketoprofen. Ethyl cellulose and shellac polymers were used for drug layering and extended release coating in the same apparatus. Inert sugar spheres were intermittently treated with drug powder and binding solution. Combination of ethyl cellulose (45cps) and shellac was evaluated as binders at different levels (1:3 ratio, at 6%, 12%, 16% and 21%w/w polymer) for drug loading and for extended release coating (1:3 ratio at 2%, 4% and 7% w/w polymer). Pellets were evaluated for drug release study using paddle apparatus in pH 6.8 Phosphate buffer, 900ml at 100 rpm. Ethyl cellulose and shellac when used as binder during drug layering did not extend the ketoprofen release beyond 4h. However, coating of drug loaded pellets using ethyl cellulose and shellac resulted in extended release profile of ketoprofen for about 10h. Ethyl cellulose coating alone at a level of 3% w/w resulted in extended release profile. Coated pellets were evaluated for sphericity, Hardness-Friability Index and scanning electron microscopy. Scanning electron micrographs of the pellets showed a uniform coating of polymer on the core pellets substantiating the use of centrifugal granulator for extended release coating. Release pattern from the optimized batch was best explained by Higuchi's model. The drug release pattern from the pellets was found to be Non-Fickian anomalous type, involving both diffusion and erosion mechanism. Accelerated stability study of the coated pellets filled in hard gelatin capsule was conducted for 3-month period and observed for the effect on drug release profile.
采用实验室规模的离心制粒仪对粉末层积技术进行评估,以制备酮洛芬缓释微丸剂型。在同一仪器中,使用乙基纤维素和虫胶聚合物进行药物层积和缓释包衣。惰性糖球间歇地用药物粉末和黏合剂溶液处理。评估了不同用量水平(聚合物比例为1:3,用量分别为6%、12%、16%和21%w/w)的乙基纤维素(45cps)和虫胶组合作为黏合剂用于药物负载和缓释包衣(聚合物比例为1:3,用量分别为2%、4%和7%w/w)的效果。使用桨法装置在pH 6.8的900ml磷酸盐缓冲液中、转速为100 rpm的条件下对微丸进行药物释放研究。在药物层积过程中,当乙基纤维素和虫胶用作黏合剂时,酮洛芬的释放时间未超过4小时。然而,使用乙基纤维素和虫胶对载药微丸进行包衣后,酮洛芬的释放曲线延长至约10小时。单独使用3%w/w的乙基纤维素包衣可实现缓释效果。对包衣微丸进行了球形度、硬度-脆碎度指数和扫描电子显微镜评估。微丸的扫描电子显微镜照片显示聚合物在核心微丸上均匀包衣,证实了离心制粒仪用于缓释包衣的可行性。优化批次的释放模式最好用Higuchi模型来解释。发现微丸的药物释放模式为非Fickian异常类型,涉及扩散和侵蚀机制。对填充在硬明胶胶囊中的包衣微丸进行了为期3个月的加速稳定性研究,并观察其对药物释放曲线的影响。